Zymeworks
(NASDAQ) ZYME
Zymeworks Financials at a Glance
Market Cap
$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$81.26M
Net Income (TTM)
-$102.66M
EPS (TTM)
-$1.37
P/E Ratio
-18.92
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$25.90
Volume
483,248.562
Open
$27.03
Price
$25.90
Volume
483,248.562
Open
$27.03
Previous Close
$25.88
Daily Range
$25.36 - $27.13
52-Week Range
$11.51 - $29.75
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$25.90
Volume
483,248.562
Open
$27.03
Previous Close
$25.88
Daily Range
$25.36 - $27.13
52-Week Range
$11.51 - $29.75
Estimated Earnings Date
Aug 6, 2026
ZYME News
3 Top Biotech Picks for 2025
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zymeworks
Industry
Biotechnology
Sector
Health CareEmployees
243
CEO
Ken Galbraith
Website
www.zymeworks.comHeadquarters
Middletown, BC V5T 1G4, CA
ZYME Financials
Key Financial Metrics (TTM)
Gross Margin
94.42%
Operating Margin
-140.35%
Net Income Margin
-126.33%
Return on Equity
-37.79%
Return on Capital
-32.27%
Return on Assets
-21.47%
Earnings Yield
-5.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
73.57M
Volume
483.25K
Avg. Volume
673.76K
Financials (TTM)
Gross Profit
$76.73M
Operating Income
-$114.05M
EBITDA
-$94.32M
Operating Cash Flow
-$75.04M
Capital Expenditure
-$2.08M
Free Cash Flow
-$76.90M
Cash & ST Invst.
$364.73M
Total Debt
$17.04M
Zymeworks Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.41M
-91.1%
Gross Profit
-$439.00K
-101.6%
Gross Margin
-18.23%
N/A
Market Cap
$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$6.37M
N/A
Employees
299
N/A
Net Income
-$44.16M
-95.1%
EBITDA
-$41.44M
-85.6%
Quarterly Fundamentals
Total Cash
$364.73M
+37.5%
Total Debt
$17.04M
-7.7%
Accounts Receivable
$4.67M
-81.0%
Inventory
$0.00
N/A
Long Term Debt
$13.76M
-9.5%
Short Term Debt
$3.28M
+0.6%
Return on Assets
-21.47%
N/A
Return on Invested Capital
-25.77%
N/A
Free Cash Flow
-$45.72M
-1120.8%
Operating Cash Flow
-$45.72M
-1241.9%